VistaGen Therapeutics (VTGN) Receives FDA Fast Track Designation for Development of PH10 to Treat Major Depressive Disorder - StreetInsider.com

Submitted by Anonymous (not verified) on Tue, 12/06/2022 - 13:33

VistaGen Therapeutics (VTGN) Receives FDA Fast Track Designation for Development of PH10 to Treat Major Depressive Disorder  StreetInsider.com